chrisvoncsefalvay/vaers-outcomes huggingface dataset:
When I tried to stand up in the morning My legs collapsed and I couldn't stand; I couldn't stand; Heart pounding, racing for 16 hrs.; My legs felt weak; worst headache for over a week .; Flu like symptoms; This is a spontaneous report from a contactable consumer (patient). A 58-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: FC3151), via an unspecified route of administration, administered in right arm on 27Aug2021 at 16:00 (at the age of 58-years) as dose 1, single for covid-19 immunization. The patient medical history included Arthritis, allergies, fibromyalgia, hiatal hernia, barrettes esophagus. The patient also had known allergies to Sulfa. The patient was not pregnant at the time of vaccination. The patient had not received any other vaccine within 4 weeks prior Covid vaccination. The patient's concomitant medications included tramadol; rabeprazole sodium (ACIPHEX); pantoprazole; anastrozole and Mov. The patient had not been diagnosed with COVID-19 prior to vaccination. After vaccination on 28Aug2021, the patient reported that she had her heart pounding, racing for 16 hrs. When she tried to stand up in the morning, her legs collapsed, and she could not stand. That happened three times then fifteen minutes later, her legs felt weak, but she was able to stand. She also had worst headache for over a week and flu like symptoms. The patient had not received any treatment for the events. The patient was tested post vaccination and the nasal swab for sars-cov-2 test showed negative result. The outcome of the events was recovered on an unspecified date in 2021.  No follow up attempts possible. No further information is expected.
About a month after the second vaccine, I first noticed a bitter, metallic taste in my mouth. Mostly savory foods. It made me lose my appetite. As I write this it's the middle of June and the bad taste is still there. Since the second vaccine, I've also regularly experienced extreme bouts of fatigue, shingle-like skin rashes, allergy symptoms (never had any seasonal allergies) At the beginning of May I had flu like symptoms over the weekend- cough, chills, sore throat, fatigue. Rapid test for COVID came back negative.
positive complement titer; swelling; Lip swelling; swelling on eyelids; ankle swelling; positive ANA titer; angeoedema; urticaria; rash; This case was reported by a consumer via sales rep and described the occurrence of angioedema in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 11th January 2019, the patient received the 1st dose of Shingrix (intramuscular). On 18th June 2019, the patient received the 2nd dose of Shingrix (intramuscular). In February 2019, less than 2 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced angioedema (serious criteria GSK medically significant), chronic urticaria and rash. In May 2019, the patient experienced antinuclear antibody positive. On an unknown date, the patient experienced complement fixation test positive, facial swelling, lip swelling, swelling of eyelid and ankle swelling. On an unknown date, the outcome of the angioedema, chronic urticaria and rash were not recovered/not resolved and the outcome of the antinuclear antibody positive, complement fixation test positive, facial swelling, lip swelling, swelling of eyelid and ankle swelling were unknown.   It was unknown if the reporter considered the angioedema, chronic urticaria, rash, antinuclear antibody positive, complement fixation test positive, facial swelling, lip swelling, swelling of eyelid and ankle swelling to be related to Shingrix. It was unknown if the reporter considered the complement fixation test positive to be related to Shingrix.  Additional details were provided as follows: The case was reported by the field representative, who was also the patient. At the end of February 2019, the patient experienced a rash and chronic urticaria with angioedema. Her face, lips, eyelids and ankles swell and this happened daily.  In May 2019, she saw an allergist and had a positive antinuclear antibody (ANA) titer. The patient also saw a rheumatologist, but all the tests for autoimmune diseases were negative except for a positive complement factor, which she expected with the reaction she had.      Lab Comments: on an unknown date, all the tests for autoimmune diseases were negative
Patient had nausea, chills, loss of appetite. She also had pain and redness on the entire surface of left upper arm where she received Pneumovax 23 and Fluzone Quad injections.
Increased joint and muscle pain; Increased joint and muscle pain; Also confusion; This is a spontaneous report from a contactable reporter (consumer or other non HCP).   A 54-year-old male patient received bnt162b2 (BNT162B2), administration date 12Jan2022 at 12:00 (Lot number: unknown) at the age of 54 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing), notes: RA - Severe Scoliosis; "Scoliosis" (unspecified if ongoing), notes: RA - Severe Scoliosis; "Joint pain" (unspecified if ongoing) and "Muscle pain" (unspecified if ongoing). Concomitant medications included: FENTYL and VIAGRA. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot Number: UNKNOWN, Administration time: 12:00), administration date: 22Dec2021, when the patient was 54 years old, for COVID-19 immunisation.  The following information was reported: ARTHRALGIA (non-serious), MYALGIA (non-serious), all with onset 12Jan2022 at 20:00, outcome "recovering", and all described as "Increased joint and muscle pain"; CONFUSIONAL STATE (non-serious) with onset 12Jan2022 at 20:00, outcome "recovering", described as "Also confusion". Therapeutic measures were not taken as a result of arthralgia, myalgia and confusional state.  Additional Information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Patient died September 7, 2021, approximately 5 months after receiving vaccine.  He was ELDERLY AND FRAIL WITH ANTIBODIES when he made life-alternating decision to take the vaccine.  He suffered a stroke event within a week of receiving vaccine; then continued to have TIA's routinely, several times a week, sometimes several times in a single day from the time he had stroke event after vaccine.   I directly link his decline and subsequent death to receiving the vaccine amid misinformation and the lack of readily available information like before you roll up your sleeve.  Dad failed to be a consumer of his healthcare and trudged to his slow death when he took vaccine.  His generation revered doctors and healthcare; often to their own detriment.
red hot feverish skin at injection site; swollen left arm; raised skin like if you cut an orange in half; pain in left arm; fatigue; achiness; rash; tingling; fever; Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red hot feverish skin at injection site), PERIPHERAL SWELLING (swollen left arm), SKIN SWELLING (raised skin like if you cut an orange in half), PAIN IN EXTREMITY (pain in left arm) and FATIGUE (fatigue) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (red hot feverish skin at injection site), PERIPHERAL SWELLING (swollen left arm), SKIN SWELLING (raised skin like if you cut an orange in half), PAIN IN EXTREMITY (pain in left arm), FATIGUE (fatigue), PAIN (achiness), RASH (rash), PARAESTHESIA (tingling), PYREXIA (fever) and DECREASED APPETITE (Loss of appetite). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and CALAMINE at an unspecified dose and frequency. At the time of the report, INJECTION SITE ERYTHEMA (red hot feverish skin at injection site), PERIPHERAL SWELLING (swollen left arm), SKIN SWELLING (raised skin like if you cut an orange in half), PAIN IN EXTREMITY (pain in left arm), FATIGUE (fatigue), PAIN (achiness), RASH (rash), PARAESTHESIA (tingling), PYREXIA (fever) and DECREASED APPETITE (Loss of appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter  No treatment was reported   This case was linked to MOD-2021-223931 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: significant follow-up added
MMR vaccine was given intramuscular in right thigh, instead of subcutaneous to upper arm
Frozen shoulder (can't raise arm above head or back to put on clothing or coat or bath my back. Can not participate in any activities I enjoy tx-PT, massage
patient reported profuse sweating and shaking 3 days after receiving the vaccine and general malaise in between.
Please note that the administration of the 4th vaccine was given at the pharmacy location being reported. We do not have detailed information regarding the vaccine series 1-3.   At Pharmacy, an intern used the incorrect size needle to administer the Covid vaccine to the patients listed on this report. The needle size used was a 5/8 inch needle, when the correct size that should have been used was a 1 inch needle. The correct dose was given to all patients. Based on CDC recommendations, there is no need to revaccinate any patient that was administered the dose in the wrong location; in this case the vaccine was given SubQ rather than intramuscular, based on the length of the needle. All patients were notified of this error and were given advise on what to expect. All patients were informed that no harm was done, the vaccine was still effective, and no additional dose is required based on CDC guidelines. As a result of these errors, reeducation was given to the pharmacy student, and the area within the pharmacy that contains all vaccination related supplied were relabeled to make it more clear for everyone administering vaccines.
Myalgia, Stiffness and tingling to RT Arm going down towards Wrist Narrative:
Hair began to fall out; Hair began break off; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair began to fall out) and TRICHORRHEXIS (Hair began break off) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Hair began to fall out) and TRICHORRHEXIS (Hair began break off). At the time of the report, ALOPECIA (Hair began to fall out) and TRICHORRHEXIS (Hair began break off) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was reported.
Patient came into pharmacy with painful and itchy red, swollen right arm, on the outside of the arm starting under the deltoid and extending to the elbow. Recommended ibuprofen and cold compresses for the pain and swelling and diphenhydramine for itching. Referred to primary doctor if symptoms did not improve and resolve within a few days or if she had worsening or systemic symptoms.
Developed approximately 5cm by 6cm erythema, swollen area at site of injection approximately 24 hours after administration. Hot and hard to touch.
Case number PHEH2015US000684, is an initial spontaneous report received from a pharmacist on 05 Jan 2015. This report refers to a 52 year old male patient. Medical history and concomitant medications were not reported. The patient was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 08 Oct 2014. It was reported that the patient received FLUVIRIN which reached temperature below 36 degree F for 3.5 non-consecutive days and 33.1 degree F for less than 12 hours. Reporter did not believe that the vaccine was frozen. She thought that it could be due to thermometer malfunction. But she was not sure. No adverse event was reported following this medication error.
Pain and weakness staring in fingers and hands, moves to wrist. Then moved to feet and knees, hips. Shoulders. The pain  and weakness has caused her to be unable to bath herself or dress herself.
Slight rash and itching at site of injection.  This occurred exactly one week after inoculation and is now in second day.
pt recvd vax; p/ 3rd dose exp autoimmune hemolytic anemia;
Information has been received from a nurse practitioner concerning a 32 year old female with hypothyroidism, no known drug allergies and a history of pregnancy who in 2000 was vaccinated on two separate dates with doses of varicella vaccine. Concomitant therapy included Synthroid. On approximately 09/28/2001, a serum varicella zoster test was performed which revealed no detectable levels of varicella zoster virus antibodies. The pt sought unspecified medical attention. The nurse practitioner noted that the pt had been lactating when the titers were drawn. Additional info has been requested.
Prior to getting covid, I had received four vaccinations by Pfizer; Prior to getting covid, I had received four vaccinations by Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Prior to getting covid, I had received four vaccinations by Pfizer". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Prior to getting covid. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Patient wanted to give feedback on the Paxlovid medication. Prior to getting covid, Patient had received four vaccinations by Pfizer. Patient found the paxlovid to Be an Effective medication. Patient was wondering if some of the rebound was caused by people stopping the medication too soon. Patient's son-in- law and daughter in (State name withheld) also took it , but patient's son-in-law had side effects and was told he could stop whenever he wanted. Patient thought it should be treated the same as an antibiotic.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
No A/E. Vaccine was stored in freezer  beyond 14 days. Was in freezer for  26 days.
14 days after receiving the vaccine, I started getting dizzy/vertigo. When i lay down on my back,  or when i tilt my head back or when i  turn my head to the left and right. The room that I am in, starts to spin. I have to stop and stand still for several seconds before I am ok. I am 61 years old and never had any dizzines/vertigo in my life before I received the vaccine. I exercise 3 times week, dont smoke, drink very little alcohol consumption. I am 5 feet 9 inches tall and weigh 165 pounds. My blood pressure is 130/80. I have been going to a chiropractor about 2 times a month for the past 20 years for regular spinal adjustments. I am an active person with no health issues.  .
SHINGRIX 50 MCG Inj (IM) SNGDSE VL10pk reaction: rash above the injection site, pain where shot was given, swelling where shot was given, feeling tired and weak.
This spontaneous report as received from a register nurse refers to her husband of unknown age. Pertinent medical history, drug reaction and allergies were not reported. On 19-SEP-2013 the patient was vaccinated with ZOSTAVAX. Concentration, route of administration and duration were not reported. Concomitant medications were not reported. On 19-SEP-2013, when the pharmacist inserted the needle into patient's arm, he felt a sting and pulled away and the needle came out. He was revaccinated successfully the second time (19-Sep-2013). The outcome of sting was unknown. The relationship between the adverse event and ZOSTAVAX was not reported. This is one of several reports from the same source. Additional information has been requested.
administration error - 2 flu vaccines administered instead of 1 flu vaccine and 1 covid vaccine. No adverse events occurred due to the error.
Felt pain cascading from left shoulder immediately after injection. Pharmacist was standing while I was sitting for the injection.  Immediately, within 5 minutes, I could not lift my left arm higher than chest level.  Pain and very limited range of motion lasted the first week.  It has not fully subsided, with continued loss of range of motion when lifting arm above shoulder level / reaching up and behind, muscle weakness when lifting objects, and pain when sleeping on left side.
PERICARDITIS; ALMOST HAD ANOTHER EVENT BEFORE; This spontaneous report received from a patient concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total administered on an unspecified date in 2021 prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, patient had pericarditis that started after he took his shot over a year ago and was taking ibuprofen but it was not helping. His doctor did not believe that it was due to the vaccine and they said because of patient's eating and patient was not healthy. Patient reported that he almost had another event before. Treatment medications (dates unspecified) included: ibuprofen.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pericarditis, and the outcome of almost had another event before was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220537184-covid-19 vaccine ad26.cov2.s-Pericarditis. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Client reports did home test - positive for pregnancy past week ago - will f/u w/dr thru another program.
Expired moderna vaccine booster dose administered to 1 patient/Dose administered greater than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccine booster dose administered to 1 patient/Dose administered greater than 12 hours post puncture) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066K21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Mar-2022 at 8:24 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2022 at 8:24 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccine booster dose administered to 1 patient/Dose administered greater than 12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired moderna vaccine booster dose administered to 1 patient/Dose administered greater than 12 hours post puncture) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Vail was first punctured on 8:06 am  28Mar2022.  No relevant concomitant medications were reported.  No treatment information was provided.
Information has been received from a physician concerning a 67 year old female who on 22-OCT-2008 was vaccinated with a dose of PNEUMOVAX 23 IM.  Concomitant therapy included influenza virus vaccine (unspecified) (manufacturer unspecified).  On 24-OCT-2008 the patient experienced headaches, swelling of the lips and eyes, itchy throat, and hives all over.  The patient went to the ER and was admitted for observations.  The patient was released on 26-OCT-2008 and re-admitted on 27-OCT-2008.  The patient had been there since because of the hives.  She was being treated with MEDROL, BENADRYL and famotidine (MSD).  Additional information has been requested.
Sore; My face swelled out; My chest hurts; I don't feel right; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Sore"; SWELLING FACE (non-serious), outcome "unknown", described as "My face swelled out"; CHEST PAIN (non-serious), outcome "unknown", described as "My chest hurts"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "I don't feel right".  Additional Information: The consumer stated, "I want to report an effect I had from the shot, it made me "sore" (further not clarified) I don't feel right (well)." When probed for the experienced effect, consume stated, "Started my face swelled out and my chest hurts."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt c/o feeling achy, fever, cough & fatigue. Thinks she has the "flu" from the from the flu shot. Is on steroids for rheumatoid arthritis.
Shot area red, swollen, painful 4x4 area 101 degree-Temp. Extreme chills, aches, pain, headache, nausea, shot on 8/28 am - sick, 8/29, 8/30,8/31,9/1 am-pm. Went  into bronchitis sinus infection. Sick 9/1-9/2.
At 1-week post vaccination, patient reported symptoms of headache, nausea, and dizziness. The severity of symptoms has decreased in severity, but are still being experienced 3+ months later.
Hives and swelling of the face.  Used Benadryl to control symptoms.  Symptoms resolved over 36 hours